ZYBERNO
Stock Report
Updated Sep 1, 2026

TENON MEDICAL, INC. (TNON)

Healthcare • NASDAQ

$4.73

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
14.0/100
POOR BUSINESS
TENON MEDICAL, INC. (TNON) scores 14/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-548.4%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (-242.7%)
Return on Capital (Capital Efficiency):CRITICAL (-117.3%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

TENON MEDICAL, INC. (TNON) stock report — Zyberno Score 14/100 (POOR BUSINESS). Full financial analysis on Zyberno.

Over the trailing twelve months, TNON generated -$11.50M in Owner Earnings. Reinvestment rate: -0.1%.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:4.73
Market Cap:$2.71M

Valuation Multiples (2)

P/S Ratio:0.51x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$2.38M

Price Action & Momentum (2)

Momentum Percentile:4 / 100
% of 52-Week High:9.4%
B. Profitability Assessment

Return Metrics (5)

ROA:-124.8%
Reinvestment Rate:-0.1%
Fundamental Growth Rate (g):0.1%

Margin Analysis (3)

Operating Margin Ttm:-242.7%
Net Margin Ttm:-257.9%
Ebitda Margin:-237.0%

TTM Performance (3)

Gross Margin Ttm:66.8%
Operating Margin Ttm:-242.7%
Net Margin Ttm:-257.9%

Yield Metrics (2)

Earnings Yield:-$266.28
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:-4,205.3%
Latest Earnings Filed:2026-08-13

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):43.8%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:0.58x
Quick Ratio:0.48x
Cash Ratio:0.20x

Leverage Analysis (1)

Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-12.44x
Times Interest Earned:-12.44

Capital Structure (4)

Working Capital:-3,498,000.00
Cash And Cash Equivalents:1,677,000.00
Long Term Debt:$1.13M
Net Debt:-$331.00K
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $5.31M
Linear Growth: 43.8%
📊 Click to view full TNON Revenue analysis & methodology →
Cost Of Revenue Ttm:$1.76M

Profitability Breakdown (2)

Gross profit TTM: $3.55M
Linear Growth: 35.4%
📊 Click to view full TNON Gross Profit analysis & methodology →
-$12.89M

Bottom Line Performance (3)

-$13.70M
Income Before Tax:-$12.56M
Ebitda Ttm:-12,587,000.00

Operating Expenses (5)

Operating Expenses:16,441,000.00
R And D Expense:2,385,000.00
Sga Expense:7,069,000.00
Income Tax Expense:$0.00
Interest Expense:1,028,000.00

Expense Ratios (3)

R And D To Revenue Percentage:186.5%
Sga To Revenue Percentage:552.7%
Ebitda Margin:-237.0%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$9.92M
Current Assets:$4.81M
Ppe Net:771,000.00
Goodwill:2,407,000.00
Intangible Assets:$455.00K

Liability Structure (4)

Total Liabilities:11,665,000.00
Current Liabilities:8,305,000.00
Long Term Debt:$1.13M
Short Term Debt:$215.00K

Equity & Capital (3)

Equity:-$1.74M
Retained Earnings:-$88.83M
Common Stock:130,000,000.00

Working Capital Items (3)

Accounts Receivable:1,947,000.00
Inventory:783,000.00
Accounts Payable:1,952,000.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:412,000.00
C. Cash Flow Analysis

Operating Activities (2)

-$11.22M-$11.65M

Investment Activities (1)

Investing Cash Flow:-$56.00K

Financing Activities (3)

Financing Cash Flow:$3.87M
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:4,010,000.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:305,000.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-14.36
-$13.74
Earnings Per Share Ttm:-$23.89

Revenue & Cash Per Share (2)

Sales Per Share Ttm:9.26
Operating Cash Flow Per Share:-$18.74

Book Value & Capital (2)

Book Value Per Share:-$3.04
Cash Per Share:2.92

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.48x
Working Capital Turnover Ttm:-999.00x

Receivables Management (2)

Receivables Turnover Ttm:2.73x
Days Sales Outstanding Ttm:133.78

Inventory Management (2)

Inventory Turnover Ttm:2.25x
Days Inventory Outstanding Ttm:162.11

Payables & Cash Cycle (2)

Days Payable Outstanding:404.13
Cash Conversion Cycle:-108.24
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:20.00
Quality Score:20.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Owner Earnings Analysis (1)

-$11.50M

Damodaran Growth Analysis (2)

Reinvestment Rate:-0.1%
Fundamental Growth Rate (g):0.1%
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Revenue Growth Rate (Linear):43.8%

Other Growth Rates (2)

Gross Profit Growth Rate (Linear):35.4%
Book Value Growth Rate (Linear):-7.3%
C. Company Profile & Context

Corporate Information (6)

Symbol:TNON
Company Name:TENON MEDICAL, INC.
Sector:Healthcare
Industry:Medical Devices
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:low
Volume Category:N/A

Share Structure (3)

Shares Outstanding:573.43K
Shares Outstanding Basic:328
Shares Outstanding Diluted:328

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-01 17:04:53 UTC
Data Timestamp:2026-08-21T23:08:02.814008
Scroll to Top